Page last updated: 2024-09-02

cinnabarinic acid and Allergic Encephalomyelitis

cinnabarinic acid has been researched along with Allergic Encephalomyelitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allegrucci, M; Belladonna, ML; Bessede, A; Busceti, C; Fallarino, F; Fazio, F; Gargaro, M; Lionetto, L; Nicoletti, F; Notartomaso, S; Scarselli, P; Simmaco, M; Vacca, C; Volpi, C; Zappulla, C1

Other Studies

1 other study(ies) available for cinnabarinic acid and Allergic Encephalomyelitis

ArticleYear
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
    Neuropharmacology, 2014, Volume: 81

    Topics: Animals; Benzopyrans; Central Nervous System; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Agonists; Male; Mice; Mice, Inbred C57BL; Myelin Basic Protein; Myelin-Oligodendrocyte Glycoprotein; Myosin Type II; Nuclear Receptor Subfamily 1, Group F, Member 3; Oxazines; Peptide Fragments; Receptors, Metabotropic Glutamate; T-Box Domain Proteins; Th17 Cells; Time Factors; Transcription Factors

2014